DPT-IPV-Hib and PCV15 are now routine vaccination.

(1) DPT-IPV-Hib (the 5 in 1) vaccination

As of April 1, 2024, a combination of Diphtheria, Pertussis, Tetanus, Polio, and Hib containing vaccine (DPT-IPV-Hib, 5 in 1) has become a routine vaccination for babies at ages 2 months, 4 months, 6 months, and 12–15 months.

The DPT-IPV (the 4-in-1) vaccine was previously used but is now replaced by the 5-in-1 vaccine for all babies born on or after February 1, 2024. Both vaccines give protection against diphtheria, tetanus, whooping cough (pertussis) and polio.  The 5-in-1 vaccine also gives protection against Hib disease (Haemophilus influenzae type b).

From April 2024, vaccination with the 5 in 1 vaccine will be the standard. However, if your child has already received vaccinations with the 4 in 1 vaccine and the Hib vaccine, he/she should in principle, complete vaccination with the same vaccine.

・The eligible children, number of doses, and inoculation intervals are the same as those for the DPT-IPV vaccine.

・In addition to subcutaneous injection, intramuscular injection will now be an option for vaccination.

For further information about the vaccine, please refer to

Vaccine Knowledge by University of OXFORD

CDC: Common combination vaccines for children

 

(2) PCV15 vaccine

Pneumococcal conjugate vaccine (PCV13, and PCV15) can prevent pneumococcal disease for infants and young children.

As of April1, 2024, PCV15 vaccine (Vaxneuvance)” has become a routine vaccination.

As for children who have completed their first, second, or third dose of vaccination using PCV13 (Prevenar) by March 2024, the remaining doses will be administered using PCV15 (Vaxneuvance).

・The eligible children, number of doses, dosage, and inoculation intervals are the same as those for the PCV13 vaccine.

・In addition to subcutaneous injection, intramuscular injection will now be an option for vaccination.

 Please refer to MedlinePlus